Comments
Loading...

Inozyme Pharma

INZYNASDAQ
Logo offerto da Benzinga Data
I risultati di Q1 2025 sono stati pubblicati in data mer mag 14th, prima dell'apertura del mercato
Inozyme Pharma (INZY) announced it will be acquired by Biomarin Pharmaceutical (BMRN) on Friday, May 16, 2025 for $270.0M paid in cash

No Unusual Options Activity in the Last 90 Days